US Broker Ratings

AbbVie Inc. (ABBV) Stock Analysis: Navigating a High Dividend Yield Amid Market Dynamics

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, is a force to be reckoned with in the world of drug manufacturing. With a market capitalization of $461.26 billion,..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Unveiling a 32.64% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector, is catching the eyes of savvy investors with its impressive market cap of $150.88 billion and a notable potential..

Mettler-Toledo International (MTD) Stock Analysis: Insights on Valuation and Growth Potential

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the Diagnostics & Research industry within the Healthcare sector, commands a significant market presence with a capitalization of $26.44 billion. Based..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a Challenging Landscape with Strategic Insights

Molina Healthcare Inc (NYSE: MOH), a leading player in the healthcare plans sector, has been a formidable participant in the U.S. healthcare market. Founded in 1980 and headquartered in Long..

Regeneron Pharmaceuticals (REGN): Investor Outlook with a Strong 27% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, an industry known for its dynamic innovation and substantial growth potential. With a market capitalization of..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating the Biotech Sector with Robust Revenue Growth

Royalty Pharma plc (NASDAQ: RPRX) stands out in the healthcare sector with a business model that leverages the intricate world of biopharmaceutical royalties. With a market capitalization of $33.27 billion,..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 58% Upside

Zoetis Inc. (NYSE: ZTS), a titan in the animal health industry, is drawing attention from investors due to its significant potential upside of 58.15%. With a market capitalization of $31.36..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust 21.87% Upside Potential Awaits Investors

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, is currently capturing the attention of investors with its promising growth potential. With a market capitalization of $91.07 billion,..

Medtronic plc (MDT) Stock Analysis: Healthcare Giant Offers a 17.53% Upside Potential

Medtronic plc (NYSE: MDT), a leading player in the healthcare sector, particularly in medical devices, presents a compelling investment case with its robust business model and promising prospects. Headquartered in..

Merck & Company, Inc. (MRK): Investor Outlook with a 2.62% Dividend Yield and Robust Buy Ratings

Merck & Company, Inc. (NYSE: MRK), a healthcare titan with a market capitalization of $319.99 billion, stands as a formidable player in the drug manufacturing industry. Operating primarily in the..

Edwards Lifesciences Corp (EW): Analyst Consensus Points to Growth Potential in the Medical Device Sector

Edwards Lifesciences Corporation (NYSE: EW), a heavyweight in the healthcare sector, is making waves with its cutting-edge cardiovascular technologies. Headquartered in Irvine, California, the company has a commanding presence in..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 19.86% Potential Upside Amid Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE), a longstanding titan in the healthcare sector, continues to capture investor interest with its robust portfolio of biopharmaceutical products and promising market dynamics. With a market..

UnitedHealth Group (UNH) Stock Analysis: Navigating Market Challenges with Strategic Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a formidable market cap of $386.29 billion. As a leader in healthcare plans, UnitedHealth offers a comprehensive range..

argenx SE (ARGX) Stock Analysis: A 11.59% Potential Upside with Strong Buy Ratings

argenx SE (NASDAQ: ARGX), a leading player in the biotechnology sector, is making waves in the market with its innovative approach to treating autoimmune diseases. With a market capitalization of..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating Growth and Valuation Challenges

Novo Nordisk A/S (NYSE: NVO), a leading player in the global healthcare sector, is known for its stronghold in the pharmaceutical industry, particularly in the areas of diabetes and obesity..

Novartis AG (NVS) Investor Outlook: Navigating a Balanced Path Amidst Market Volatility

Novartis AG (NYSE: NVS), a heavyweight in the global pharmaceutical industry, remains a focal point for investors seeking both stability and growth potential in the healthcare sector. With a substantial..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Becton, Dickinson and Company (NYSE: BDX), a prominent player in the healthcare sector, stands out as a key manufacturer and supplier of medical supplies and diagnostic equipment. With a market..

Sanofi (SNY) Stock Analysis: Exploring a 29% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a global leader in the healthcare sector, presents an intriguing investment opportunity for those seeking exposure to the pharmaceutical industry. With a market capitalization of $103.32 billion, the..

Haleon plc (HLN) Stock Analysis: Unlocking an 18.64% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust product portfolio and significant potential upside. Headquartered in Weybridge, United..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the 101% Return on Equity Amid a Diverse Portfolio

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of therapeutics and impressive financial metrics. As a leading player in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds